Cargando…

Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report

INTRODUCTION: Oxalate nephropathy has various etiologies and remains a rare cause of renal failure. To the best of our knowledge, we report the first case of oxalate nephropathy following octreotide therapy. CASE PRESENTATION: We report the case of a 78-year-old Caucasian man taking chronic octreoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gariani, Karim, de Seigneux, Sophie, Courbebaisse, Marie, Lévy, Marc, Moll, Solange, Martin, Pierre-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416724/
https://www.ncbi.nlm.nih.gov/pubmed/22823940
http://dx.doi.org/10.1186/1752-1947-6-215
_version_ 1782240431633858560
author Gariani, Karim
de Seigneux, Sophie
Courbebaisse, Marie
Lévy, Marc
Moll, Solange
Martin, Pierre-Yves
author_facet Gariani, Karim
de Seigneux, Sophie
Courbebaisse, Marie
Lévy, Marc
Moll, Solange
Martin, Pierre-Yves
author_sort Gariani, Karim
collection PubMed
description INTRODUCTION: Oxalate nephropathy has various etiologies and remains a rare cause of renal failure. To the best of our knowledge, we report the first case of oxalate nephropathy following octreotide therapy. CASE PRESENTATION: We report the case of a 78-year-old Caucasian man taking chronic octreotide treatment for acromegaly who presented with acute oxalate nephropathy after antibiotic therapy. The diagnosis was confirmed by urinary analysis and a kidney biopsy. The recovery of renal function was favorable after hydration and withdrawal of octreotide therapy. CONCLUSIONS: Oxalate nephropathy should be suspected in patients at risk who present with acute kidney injury after prolonged antibiotic treatment. This diagnosis should be distinguished from immuno-allergic interstitial nephritis and requires specific care. The evolution of this condition may be favorable if the pathology is identified correctly. Octreotide therapy should be considered a risk factor for enteric oxaluria.
format Online
Article
Text
id pubmed-3416724
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34167242012-08-11 Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report Gariani, Karim de Seigneux, Sophie Courbebaisse, Marie Lévy, Marc Moll, Solange Martin, Pierre-Yves J Med Case Rep Case Report INTRODUCTION: Oxalate nephropathy has various etiologies and remains a rare cause of renal failure. To the best of our knowledge, we report the first case of oxalate nephropathy following octreotide therapy. CASE PRESENTATION: We report the case of a 78-year-old Caucasian man taking chronic octreotide treatment for acromegaly who presented with acute oxalate nephropathy after antibiotic therapy. The diagnosis was confirmed by urinary analysis and a kidney biopsy. The recovery of renal function was favorable after hydration and withdrawal of octreotide therapy. CONCLUSIONS: Oxalate nephropathy should be suspected in patients at risk who present with acute kidney injury after prolonged antibiotic treatment. This diagnosis should be distinguished from immuno-allergic interstitial nephritis and requires specific care. The evolution of this condition may be favorable if the pathology is identified correctly. Octreotide therapy should be considered a risk factor for enteric oxaluria. BioMed Central 2012-07-23 /pmc/articles/PMC3416724/ /pubmed/22823940 http://dx.doi.org/10.1186/1752-1947-6-215 Text en Copyright ©2012 Gariani et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gariani, Karim
de Seigneux, Sophie
Courbebaisse, Marie
Lévy, Marc
Moll, Solange
Martin, Pierre-Yves
Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
title Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
title_full Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
title_fullStr Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
title_full_unstemmed Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
title_short Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
title_sort oxalate nephropathy induced by octreotide treatment for acromegaly: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416724/
https://www.ncbi.nlm.nih.gov/pubmed/22823940
http://dx.doi.org/10.1186/1752-1947-6-215
work_keys_str_mv AT garianikarim oxalatenephropathyinducedbyoctreotidetreatmentforacromegalyacasereport
AT deseigneuxsophie oxalatenephropathyinducedbyoctreotidetreatmentforacromegalyacasereport
AT courbebaissemarie oxalatenephropathyinducedbyoctreotidetreatmentforacromegalyacasereport
AT levymarc oxalatenephropathyinducedbyoctreotidetreatmentforacromegalyacasereport
AT mollsolange oxalatenephropathyinducedbyoctreotidetreatmentforacromegalyacasereport
AT martinpierreyves oxalatenephropathyinducedbyoctreotidetreatmentforacromegalyacasereport